In a global phase 1/2 clinical trial, sotorasib “demonstrated meaningful anticancer activity in patients with heavily pre-treated KRAS G12C–mutated advanced pancreatic cancer.”
The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
A family history of cancer andgenetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer.
Tomi Akinyemiju, PhD, DCI epidemiologist and associate director, COEE, has received Duke funds to research climate change, radon exposure & lung cancer.
Amanda Randles, PhD, will use the Pioneer Award to create AI models that estimate a person’s blood flow dynamics over time with the help of wearable devices like smart watches.
A team led by Duke biochemistry professor Bruce Donald, PhD, has developed an algorithm to predict how mutations in an enzyme will affect a drug’s efficacy.
The Radiation Research Society bestowed its highest honor — the Failla Memorial Lecture Award — on Michael B. Kastan, MD, PhD, executive director of DCI.
Congratulations to David Kirsch, MD, PhD, whose NCI Outstanding Investigator Award to study radiation and sarcoma biology has been renewed for another 7 years.
DCI radiation oncologist Christine Eyler, MD, PhD, was awarded an NCI Mentored Clinical Scientist Research Career Development Award for rectal cancer and chemo-radiotherapy research.
Brent Hanks, MD, PhD, and his lab team will trial a drug that targets the NLRP3 pathway, so as to unblock immunotherapy from working in melanoma patients.
Zach Reitman, MD, PhD, was awarded an NCI Mentored Clinical Scientist Research CDA for research into targeted radiation therapy in pediatric brainstem tumors.
Five questions for gynecologic oncologist Brittany Davidson, MD, about the best approach to patient goals and treatment expectations in terminal ovarian cancer
New nanoparticle shape can greatly enhance signals from multiple separate biomarkers at once, accurately detecting head and neck cancers without biopsies to improve global health
"Just ASK," a course developed and piloted at DCI by Nadine Barrett, PhD, to help improve equity, diversity, and inclusion in cancer clinical trials, has gone national.
A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.
Trudy G. Oliver, PhD, has joined DCI from the Huntsman Cancer Institute as a Duke Science and Technology Scholar. Her research focuses on subtypes of lung cancer.
Association was evident for patients of different ethnicities, those with government and private insurance, and those treated at different types of health care facilities.
While considered a single ethnic group, the differences found in the occurrence and outcomes of glioma brain tumor patients suggests important diversity.
DCI GI oncologist John Strickler, MD, to present positive topline results of a pivotal phase 2 homegrown clinical trial in HER2+ metastatic colorectal cancer.
John Wayne Cancer Foundation is funding research by breast surgical oncologist Maggie DiNome, MD, to create a molecular-based way to predict cancer spread to lymph nodes.
Black, Hispanic, Asian-American people and other groups have a higher risk for stomach cancer. Early detection & treatment of a common stomach bacterium can prevent it.
Christopher Counter, PhD, associate director of Basic Research, is a member of a group receiving an international Cancer Grand Challenges Grant to investigate origins of cancer.
Enabling or inhibiting a certain enzyme could trigger the body’s natural immune response according to a study in Natureby Duke immunologistEdward Miao, MD, PhD, and colleagues.
DCI study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation
DCI cancer disparities and healthcare delivery researchers Steven Patierno, PhD, and Nadine Barrett, PhD, are part of national efforts to mitigate cancer health disparities.